Park Ha Biological Technology Co. vs Research Frontiers
Park Ha Biological Technology Co. is the larger business, with $2.5m of revenue in fiscal 2025 against $1.1m for Research Frontiers (2.3 times as much). Park Ha Biological Technology Co. grew faster (6.0% against -16.0%). Research Frontiers kept more of each dollar of sales as profit: a net margin of -182.4% against -965.0%. Park Ha Biological Technology Co. carries less debt relative to equity (0.0% against 0.0%).
| Latest fiscal year | Park Ha Biological Technology Co.BYAH, 2025 | Research FrontiersREFR, 2025 |
|---|---|---|
| Revenue | $2.5m | $1.1m |
| Revenue growth | 6.0% | -16.0% |
| Net income | −$24.4m | −$2.0m |
| Operating margin | -956.5% | -190.2% |
| Net margin | -965.0% | -182.4% |
| Return on equity | — | -115.6% |
| Free cash flow | −$2,973 | −$1.3m |
| Cash | $3.8m | $664,299 |
| Total debt | $0 | $0 |
| Debt to equity | 0.0% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | — |
| Market value | $1.1m | $12.2m |
| Price vs our value range | — | — |
| Moat score | — | 18 (Weak) |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 0 sales |